CXCL8 and rheumatoid arthritis: Levels of serum IL-8 have been shown to be significantly decreased in rheumatoid arthritis (RA) patients on anti-TNF-a therapy [34] and reduced IL-8 production may reflect a significant amelioration in the inflammatory state of RA patients[35].